ผลต่างระหว่างรุ่นของ "หน้าหลัก"
Sleep86leg (คุย | มีส่วนร่วม) ล |
Beach32male (คุย | มีส่วนร่วม) ล |
||
แถว 1: | แถว 1: | ||
− | + | Ained bioavailable in plasma. Conversely, RBC MP {levels|ranges|amounts|stages | |
− | + | Ained bioavailable in plasma. Conversely, RBC MP concentrations were being greater in regular condition SCD MP, with improved mean fluorescence intensities (MFI), but very similar sizing vs. controls. SCD MP bore much more PS readily available to annexin-A5 at their area and the equilibrium between PS and annexin-A5 was compromised. In VOC, MP degrees were being improved even more and bore cytotoxic heme and CD235a. We continue to found nearly no ligand-free annexin-A5.This prompt that endogenous annexin-A5 may be eaten by extra PS externalization in SCD, and inadequate to neutralize the higher amounts of PS' MP made by RBC through hemolysis. In SCD, the therapeutic use of recombinant annexin-A5 may perhaps therefore assistance compensate the imbalance in between PS' MP and annexin-A5.PT2.Exosomes launched from sulforaphane-treated fibroblasts shield the cardiomyocytes from angiotensin II-induced hypertrophy Gaia Papini1, Marco Matteucci1, Enrica Ciofini1,2, Vincenzo Lionetti1,one Scuola Superiore Sant'Anna, Institute of Life Sciences, Pisa, Italy; 2Fondazione Toscana ``G. Monasterio'', Pisa, ItalyPT2.An imbalance in between circulating microparticles and annexin-A5 might advertise vascular personal injury through sickle cell condition Sihem Sadoudi1, Dominique Charue2, Chantal Boulanger2, Sylvain Le Jeune3 and Olivier Blanc-Brude1 INSERM; 2Institute of Health and Medical Analysis, Paris, France; 3Assistance Publique-Hopitaux De Paris, Paris, FranceChronic hemolytic anemia, like sickle cell disease (SCD) is characterised by distressing vaso-occlusive crises (VOC), vascular personal injury, red blood mobile (RBC) aggregation and vesiculation, and intravascular hemolysis. At continuous state, RBC release haemoglobin, heme and microparticles (MP) [https://www.ncbi.nlm.nih.gov/pubmed/27907933 PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/27907933] in plasma. This improves all over again two-fold during VOC. MP from pressured RBC express phosphatidylserine (PS) at their area and include cytotoxic heme. Conversely, annexinA5 is surely an intracellular protein introduced in plasma during mobile tension. Annexin-A5 acts to be a PS inhibitor, neutralizing PS-mediated effects in stressed cells and MP. We collected plasma from cohorts of SCD patients through continual state, or VOC, and controls. We created a novel ELISA-based assay to seize PS' MP with the anti-annexin-A5 antibody. It quantified annexin-A5-covered MP in plasma, and also estimated ligand-free useful annexin-A5. We characterized plasma MP by FACS with labelling of ligand-free PS with annexin-Introduction: The communication between fibroblasts and cardiomyocytes underlies the pathological cardiac hypertrophy induced by angiotensin-II (AngII), which contributes to coronary heart failure. Fibroblastderived exosomes (F-Exo) are actually implicated in mediating AngII-induced cardiomyocyte hypertrophy. Nevertheless, how release of anti-hypertrophic F-Exo is induced, stays an unanswered problem. Sulforaphane (SFN), a in a natural way transpiring isothiocyanate extracted from cruciferous veggies, attenuates AngII-induced cardiomyocytes hypertrophy. We analyzed the effects of SFN on the launch of anti-hypertrophic F-Exo in vitro. Approaches: Murine embryo fibroblasts ended up treated with non-toxic dose of SFN (three mM/7 days). Intact F-Exo ended up isolated from cell tradition media by differential centrifugation. F-Exo were being quantified by Western blot applying CD63. Hypertrophy of HL-1 cardiomyocytes [https://www.ncbi.nlm.nih.gov/pubmed/17763406 PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/17763406] was induced by AngII (a hundred nM/12 h). Cell viability was assessed by MTT assay. Cell surface area region, an indicator of cell hypertrophy, was measured just after 3 or 24 h incubation with thirty mg exosomes isolated from SFN-treated (SFN-F-Exo). | |
− | |||
− | |||
− | |||
− | |||
− | |||
− |
รุ่นแก้ไขเมื่อ 11:49, 27 ตุลาคม 2564
Ained bioavailable in plasma. Conversely, RBC MP {levels|ranges|amounts|stages Ained bioavailable in plasma. Conversely, RBC MP concentrations were being greater in regular condition SCD MP, with improved mean fluorescence intensities (MFI), but very similar sizing vs. controls. SCD MP bore much more PS readily available to annexin-A5 at their area and the equilibrium between PS and annexin-A5 was compromised. In VOC, MP degrees were being improved even more and bore cytotoxic heme and CD235a. We continue to found nearly no ligand-free annexin-A5.This prompt that endogenous annexin-A5 may be eaten by extra PS externalization in SCD, and inadequate to neutralize the higher amounts of PS' MP made by RBC through hemolysis. In SCD, the therapeutic use of recombinant annexin-A5 may perhaps therefore assistance compensate the imbalance in between PS' MP and annexin-A5.PT2.Exosomes launched from sulforaphane-treated fibroblasts shield the cardiomyocytes from angiotensin II-induced hypertrophy Gaia Papini1, Marco Matteucci1, Enrica Ciofini1,2, Vincenzo Lionetti1,one Scuola Superiore Sant'Anna, Institute of Life Sciences, Pisa, Italy; 2Fondazione Toscana ``G. Monasterio, Pisa, ItalyPT2.An imbalance in between circulating microparticles and annexin-A5 might advertise vascular personal injury through sickle cell condition Sihem Sadoudi1, Dominique Charue2, Chantal Boulanger2, Sylvain Le Jeune3 and Olivier Blanc-Brude1 INSERM; 2Institute of Health and Medical Analysis, Paris, France; 3Assistance Publique-Hopitaux De Paris, Paris, FranceChronic hemolytic anemia, like sickle cell disease (SCD) is characterised by distressing vaso-occlusive crises (VOC), vascular personal injury, red blood mobile (RBC) aggregation and vesiculation, and intravascular hemolysis. At continuous state, RBC release haemoglobin, heme and microparticles (MP) PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/27907933 in plasma. This improves all over again two-fold during VOC. MP from pressured RBC express phosphatidylserine (PS) at their area and include cytotoxic heme. Conversely, annexinA5 is surely an intracellular protein introduced in plasma during mobile tension. Annexin-A5 acts to be a PS inhibitor, neutralizing PS-mediated effects in stressed cells and MP. We collected plasma from cohorts of SCD patients through continual state, or VOC, and controls. We created a novel ELISA-based assay to seize PS' MP with the anti-annexin-A5 antibody. It quantified annexin-A5-covered MP in plasma, and also estimated ligand-free useful annexin-A5. We characterized plasma MP by FACS with labelling of ligand-free PS with annexin-Introduction: The communication between fibroblasts and cardiomyocytes underlies the pathological cardiac hypertrophy induced by angiotensin-II (AngII), which contributes to coronary heart failure. Fibroblastderived exosomes (F-Exo) are actually implicated in mediating AngII-induced cardiomyocyte hypertrophy. Nevertheless, how release of anti-hypertrophic F-Exo is induced, stays an unanswered problem. Sulforaphane (SFN), a in a natural way transpiring isothiocyanate extracted from cruciferous veggies, attenuates AngII-induced cardiomyocytes hypertrophy. We analyzed the effects of SFN on the launch of anti-hypertrophic F-Exo in vitro. Approaches: Murine embryo fibroblasts ended up treated with non-toxic dose of SFN (three mM/7 days). Intact F-Exo ended up isolated from cell tradition media by differential centrifugation. F-Exo were being quantified by Western blot applying CD63. Hypertrophy of HL-1 cardiomyocytes PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/17763406 was induced by AngII (a hundred nM/12 h). Cell viability was assessed by MTT assay. Cell surface area region, an indicator of cell hypertrophy, was measured just after 3 or 24 h incubation with thirty mg exosomes isolated from SFN-treated (SFN-F-Exo).